Elements of clinical report Flashcards

(49 cards)

1
Q

What Genomic variants does it include?

A

Somatic (potentially actionable)
Somatic (biologically relevant)
Germline (Pathogenic /likely pathogenic)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Also included: Immunotherapy markers, which are?

A
  • TMB

- MSI status

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What do they mean?

A

if a patient is a candidate for immunotherapy or not.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Also included: Treatment implications

A
  • FDA approved therapies, current diagnosis
  • FDA approved therapies, other types
  • Additional indicators (variants detected in patient sample)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What happens once the report is done?

A

A lab director signs off on the report so it can be returned to the appropriate physician.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Process of determining if variants detected are pathogenic. VUS or benign

A

variant analysis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

targeted therapies added to the report based on patients unique molecular profile

A

Therapy application

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Immunotherapy markers which are included in the report

A

TMB and MSI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

The first step in this is to filter the raw data from sequencing

A

Bioinformatics pipeline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Report delivery

A

Report is uploaded to the portal and provider/care team is notified

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How are they notified?

A
  • Fax report
  • email-based delivery (no PHI) contains a link to a secure portal
  • custodian path labs may opt-in to receive a report via fax.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is this controlled in?

A

Salesforce

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What does QNS mean?

A

Quality/Quantity not sufficient

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What does ATR stand for?

A

Additional Tissue Request

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Intro to variant classification

A
  • Somatic vs. Germline
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is Genomic testing about?

A

Detection and Interpretation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What does “Wildtype” mean?

A

Refers to the non-mutated form of a gene. (The “normal” condition)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What’s an example of this?

A

If a person is “wild type” they are considered normal across the gene pool and have no mutations present.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What’s the opposite?

A

Mutation/ alteration/variant allele

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What are the 3 main questions variant scientists need to ask?

A
  1. ) is there a mutation present?
  2. ) Does the mutation impact the protein?
  3. ) Does that impact make a difference clinically? would this need to be shown in the report.
21
Q

What are the tiers to classify?

A

Tier I
Tier II
Tier III
Tier IV

22
Q

Tier I

A

Variants of strong clinical significance

23
Q

Tier II

A

Variants of potential clinical significance

24
Q

Tier III

A

Variants of unknown clinical significance

25
Tier IV
Benign or likely benign variants
26
Wildtype meaning
"Normal" or "typical" gene form
27
Which are sources of evidence for variant classification?
- Medical/scientific literature - Internal database - Curated database
28
Two main types of molecular profiling in Cancer
1. ) Somatic | 2. ) Germline
29
What are Somatic variables?
- Potentially actionable - Biologically relevant - VUS - Pertinent negative
30
What are Germline variables?
- Pathogenic - Likely pathogenic - Germline VUS's (on xG report) - benign and likely benign
31
Somatic characteristics
- Alteration in DNA of tumor - Alters the associated protein - creates an associated therapy
32
Somatic: biologically relevant
- Alteration in DNA of tumor - Alters the associated protein - No specific therapy involved
33
Germline (in every cell of the body)
Pathogenic or likely pathogenic
34
Germline characteristics
- alteration in DNA of every cell in the body - known to alter the associated protein - leads to an increased risk of certain cancers - partial explanation for development of current cancer
35
Somatic "Negative" results are also called:
Pertinent Negative
36
What is pertinent negative?
in these genes, the lack of a mutation has therapeutic implications.
37
Germline "Negative" results are also called:
Benign/likely benign
38
What does that mean?
no variant was detected in the genes tested or variants therefore have no clinical impact.
39
What does VUS stand for?
Variants of uncertain significance
40
What is a VUS exactly?
an alteration in DNA of every cell in the body or in the tumor.
41
VUS facts to know:
- NOT clinically actionable - NOT a false positive - Classified as a VUS because there is no evidence, not enough evidence to say what it is. - may be reclassified in the future - Germline VUS reported for xG but not xT - Somatic VUS's exist, and are reported by Tempus on xT.
42
If there is a reclassification on the report, what happens?
GeneDx will reclassify the variant and Tempus will issue an amended report.
43
Variants look different on each report, true or false?
True.
44
Takeaways
- detecting and classification are important. - scientists use multiple lines of evidence to classify - somatic variants include those that are potentially actionable, biologically relevant and pertinent negatives. - germline variants include pathogenic/likely pathogenic variants as well as variants of unknown significance.
45
Reportable somatic variants include:
- potentially actionable - biologically relevant - pertinent negatives - VUS
46
Reportable germline variants include:
- pathogenic - likely pathogenic - variants of unknown significance
47
what does the depth of coverage mean?
how many times path reads a part of the gene. Ex. 500
48
TAT begins when?
The lab receives the sample
49
What's the main database to be aware of?
OncoKB database (appears on our reports if we get that)